Analyses of clandestine tablets of amphetamines and their related designer drugs encountered in recent Japan

Japanese Journal of Forensic Toxicology

Volumn 20, Issue 3, 2002, Pages 303-319

  Katagi, Munehiro ^a   Tsutsumi, Hiroe ^a   Miki, Akihiro ^a   Nakajima, Kunio ^a   Tsuchihashi, Hitoshi ^a  

^a OSAKA PREFECTURE UNIVERSITY   (Japan)

Author keywords

Amphetamines; Clandestine tablets; Designer drugs; GC MS; IR; LC MS; NMR

Indexed keywords

2,5 DIMETHOXY 4 ETHYLTHIOPHENETHYLAMINE; 2,5 DIMETHOXY 4 PROPYLTHIOPHENETHYLAMINE; 3,4 METHYLENEDIOXYAMPHETAMINE; 4 BROMO 2,5 DIMETHOXYPHENETHYLAMINE; 4 METHOXYAMPHETAMINE; 4 METHYLTHIOAMPHETAMINE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; DESIGNER DRUG; PIPERAZINE DERIVATIVE; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; GAS CHROMATOGRAPHY; INFRARED SPECTROSCOPY; JAPAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; TABLET FORMULATION;

EID: 0036445446     PISSN: 09159606     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Katagi, M., Miki A., Tatsuno, M., Nakajima, K. and Tsuchihashi, H.: Enantiomeric screening of methamphetamine in urine by EMIT®. Jpn J Forensic Toxicol, 19, 206-217 (2001).
2. Matsushima, K., Nagai, T., Akuzawa, H., Saotome, A., Yanagisawa, Y., Kurosu, A. and Tokudome, S.: Optical activity form of abused methamphetamine in Tochigi and Gunma prefectures. Jpn J Sci Tech Iden, 4, 77-82 (2000).
3. Amemiya, M. and Nagai, T.: Enantiomeric investigation on methamphetamine in the abusers' urine and crystal specimens. Jpn J Forensic Toxicol, 19, 29-37 (2001).
4. Katagi, M., Tatsuno, M., Miki, A., Nishikawa, M. and Tsuchihashi, H.: Discrimination of dimethylamphetamine and methamphetamine use: Simultaneous determination of dimethylamphetamine N-oxide and other metabolites in urine by high-performance liquid chromatography-electrospray ionization mass spectrometry. J Anal Toxicol, 24, 354-358 (2000).
5. Miki, A., Katagi, M., Tatsuno, M., Nakajima, K. and Tsuchihashi, H.: Discrimination of dimethylamphetamine use from methamphetamine use by a rapid urinalysis procedure based on the GC-MS determination. Jpn J Forensic Toxicol, 19, 46-57 (2000).
6. Kraemer, T. and Maurer, H.H.: Determination of amphetamine, methamphetamine and amphetamine-derived designer drugs or medicaments in blood and urine. J Chromatogr B, 713, 163-187 (1998).
7. Aalberg, L., Deruiter, J., Noggle, F.T., Sippola, E. and Clark, C.R.: Chromatographic and mass spectral methods of identification for the side-chain and ring regioisomers of methylenedioxymethamphetamine. J Chromatogr Sci, 38, 329-337 (2000).
8. Geiser, L., Cherkaoui, S. and Veuthey, J.L.: Simultaneous analysis of some amphetamine derivatives in urine by nonaqueous capillary electrophoresis coupled to electrospray ionization mass spectrometry. J Chromatogr A, 895, 111-121 (2000).
9. Valentine, J.L. and Middleton, R.: GC-MS identification of sympathomimetic amine drugs in urine: Rapid methodology applicable for emergency clinical toxicology. J Anal Toxicol, 24, 211-222 (2000).
10. Bell, S.E., Burns, D.T., Dennis, A.C. and Speers, J.S.: Rapid analysis of ecstasy and related phenethylamines in seized tablets by Raman spectroscopy. Analyst, 125, 541-544 (2000).
11. 6-monoacetylmorphine in urine samples by GC/MS as evidence of heroin use. J Anal Toxicol, 9, 134-138 (1985).
12. Katagi, M., Nishikawa, M., Tatsuno, M., Miki, A., Nishioka, H., Nakajima, K. and Tsuchihashi, H.: Analyses of tablets containing amphetamine and heroin by gas chromatography/mass spectrometry and high-performance liquid chromatography/mass spectrometry. Jpn J Forensic Toxicol, 17, 171-179 (1999).
13. Nichols, D.E.: Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: Entactogens. J Psychoactive Drugs, 18, 305-313 (1986).
14. Nichols, D.E., Hoffman, A.J., Oberlender, R.A., Jacob, P. and Shulgin, A.T.: Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamines: Representatives of a novel therapeutic class. J Med Chem, 29, 2009-2015 (1986).
15. Gouzoulis, E., Steiger, A., Ensslin, H.K., Kavar, K.A. and Hermle, L.: Sleep EEG effects of 3,4-methylenedioxyethylamphetamine (MDE, "Eve") in healthy volunteers. Biol Psychiat, 32, 1108-1117 (1992).
16. Baselt, R.C. and Cravey, R.H.: Disposition of Toxic Drugs and Chemicals in Man, 4th Ed., Chemical Toxicology Institute, Foster City, 1995, pp. 494-495.
17. Glennon, R.A., Ismaiel, A.E.M., Martin, B., Poff, D. and Sutton, M.: A preliminary behavioral investigation of PMMA, the 4-methoxy analog of methamphetamine. Pharmacol Biochem Behav, 31, 9-13 (1988).
18. Glennon, R.A. and Higgs, R.: Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline. Pharmacol Biochem Behav, 43, 759-763 (1992).
19. Glennon, R.A., Young, R., Dukat, M. and Cheng, Y.: Initial characterization of PMMA as a discriminative stimulus. Pharmacol Biochem Behav, 57, 151-158 (1997).
20. Cimbura, G.: PMA death in Ontario. Can Med Assoc J, 110, 1263-1267 (1974).
21. Felgata, H.E., Felgata, P.D., James, R.A., Sims, D.N. and Vozzo, D.C.: Recent paramethoxyamphetamine death. J Anal Toxicol, 22, 169-172 (1998).
22. Logan B.K.: Amphetamines: An update on forensic issues. J Anal Toxicol, 25, 400-404 (2001).
23. Dal Cason, T.A.: The identification of 4-methoxyamphetamine (PMMA) and 4-methoxymethamphetamine (PMMA). Microgram, 33, 207-222 (2000).
24. Lora-Tamayo, C., Tena, T. and Rodriguez, A.: Amphetamine derivative related deaths. Forensic Sci Int, 85, 149-157 (1997).
25. Bailey, K., Legault, D. and Verner, D.: The identification of methoxyamphetamines, methoxy-N-methylamphetamines and methylenedioxyamphetamine. Microgram, 6, 141-165 (1973).
26. Bailey, K., By, A.W., Legault, D. and Verner D.: The identification of the N-methylated analogs of the hallucinogenic amphetamines and some isomers. J Assoc Off Anal Chem, 58, 62-69 (1975).
27. Clark, C.C.: The identification of methoxy-N-methylamphetamines. J Forensic Sci, 29, 1056-1071 (1984).
28. Katagi, M. and Tsuchihashi, H.: Update on clandestine amphetamines and their analogues recently seen in Japan. J Health Sci, 48, 14-21 (2002).
29. Giround, C., Augsburger, M., Rivier, L., Mangin, P., Sadeghipour, F., Varesio, E., Veuthey, J.L. and Kamalaprija, P.: 2C-B: a new psychoactive phenylethylamine recently discovered in ecstacy tablets sold on the Swiss black market. J Anal Toxicol, 22, 345-354 (1998).
30. DeRuiter, J., Clark, C.R. and Noggle, F.T.: Analysis of the bromination products of the isomeric dimethoxyphenethylamines: Differentiation of «Nexus» from five positional isomers. Microgram, 30, 96-111 (1997).
31. Zimmerman, M.M.: The identification of 2,5-dimethoxy-4-(N)-propylthiophenethylamine (2C-T-7). Microgram, 34, 169-173 (2001).
32. Chamakura, R.P.: Tryptamines. Microgram, 27, 316-329 (1994).
33. U. S. Drug Enforcement Administration: Piperazines in Roanoke, Virginia. Microgram, 34, 43 (2001).
34. Huang, X., Marona-Lewicka, D. and Nichols, D.E.: p-Methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent. Eur J Pharmacol, 229, 31-38 (1992).
35. Poortman, A.J.: The identification of 4-methylthioamphetamine. Microgram, 31, 174-180 (1998).
36. Elliott, S.P.: Analysis of 4-methylthioamphetamine in clinical specimens. Ann Clin Biochem, 38, 339-347 (2001).